Atossa Genetics Current Ratio 2012-2019 | ATOS
Atossa Genetics current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Atossa Genetics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-06-30 | $0.02B | $0.00B | 17.80 |
| 2019-03-31 | $0.02B | $0.00B | 13.94 |
| 2018-12-31 | $0.01B | $0.00B | 3.96 |
| 2018-09-30 | $0.01B | $0.00B | 3.92 |
| 2018-06-30 | $0.02B | $0.00B | 5.45 |
| 2018-03-31 | $0.01B | $0.00B | 7.96 |
| 2017-12-31 | $0.01B | $0.00B | 6.45 |
| 2017-09-30 | $0.00B | $0.00B | 2.75 |
| 2017-06-30 | $0.00B | $0.00B | 2.09 |
| 2017-03-31 | $0.00B | $0.00B | 1.96 |
| 2016-12-31 | $0.00B | $0.00B | 3.11 |
| 2016-09-30 | $0.01B | $0.00B | 5.28 |
| 2016-06-30 | $0.00B | $0.00B | 1.66 |
| 2016-03-31 | $0.00B | $0.00B | 2.55 |
| 2015-12-31 | $0.00B | $0.00B | 1.72 |
| 2015-09-30 | $0.01B | $0.00B | 2.90 |
| 2015-06-30 | $0.01B | $0.00B | 4.03 |
| 2015-03-31 | $0.01B | $0.00B | 3.26 |
| 2014-12-31 | $0.01B | $0.00B | 4.13 |
| 2014-09-30 | $0.01B | $0.00B | 7.61 |
| 2014-06-30 | $0.02B | $0.00B | 9.39 |
| 2014-03-31 | $0.02B | $0.00B | 16.36 |
| 2013-12-31 | $0.01B | $0.00B | 4.82 |
| 2013-09-30 | $0.01B | $0.00B | 4.43 |
| 2013-06-30 | $0.01B | $0.00B | 3.02 |
| 2013-03-31 | $0.00B | $0.00B | 2.15 |
| 2012-12-31 | $0.00B | $0.00B | 1.21 |
| 2012-09-30 | $0.00B | $0.00B | 0.39 |
| 2012-06-30 | $0.00B | 0.00 | |
| 2012-03-31 | $0.00B | 0.00 | |
| 2011-12-31 | $0.00B | 0.00 | |
| 2011-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.016B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $113.551B | 24.19 |
| Intuitive Surgical (ISRG) | United States | $65.033B | 51.11 |
| Edwards Lifesciences (EW) | United States | $47.253B | 45.99 |
| IDEXX Laboratories (IDXX) | United States | $24.009B | 60.23 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $20.738B | 13.92 |
| Olympus (OCPNY) | Japan | $18.466B | 138.68 |
| Teleflex (TFX) | United States | $15.275B | 32.42 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.453B | 0.00 |
| DexCom (DXCM) | United States | $14.282B | 211.65 |
| Hologic (HOLX) | United States | $13.146B | 20.75 |
| Sysmex ADR (SSMXY) | Japan | $13.040B | 35.10 |
| STERIS (STE) | Ireland | $11.903B | 27.45 |
| Varian Medical Systems (VAR) | United States | $10.592B | 25.34 |
| ABIOMED (ABMD) | United States | $7.985B | 45.71 |
| Masimo (MASI) | United States | $7.757B | 47.06 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
| Integra LifeSciences Holdings (IART) | United States | $5.284B | 23.58 |
| Penumbra (PEN) | United States | $5.136B | 184.54 |
| Globus Medical (GMED) | United States | $5.094B | 32.33 |
| Elekta AB (EKTAY) | Sweden | $4.929B | 37.94 |
| Tandem Diabetes Care (TNDM) | United States | $3.720B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.645B | 27.80 |
| Cantel Medical (CMD) | United States | $2.931B | 29.60 |
| Nevro (NVRO) | United States | $2.654B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.619B | 26.36 |
| Wright Medical Group (WMGI) | Netherlands | $2.577B | 226.00 |
| Integer Holdings (ITGR) | United States | $2.440B | 17.26 |
| Glaukos (GKOS) | United States | $2.301B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.982B | 36.77 |
| OPKO Health (OPK) | United States | $1.311B | 0.00 |
| Veracyte (VCYT) | United States | $1.269B | 0.00 |
| Natus Medical (NTUS) | United States | $1.123B | 26.15 |
| Inogen (INGN) | United States | $1.086B | 26.62 |
| Silk Road Medical (SILK) | United States | $1.073B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.008B | 31.67 |
| Mesa Laboratories (MLAB) | United States | $0.932B | 38.76 |
| Accelerate Diagnostics (AXDX) | United States | $0.916B | 0.00 |
| Luminex (LMNX) | United States | $0.905B | 0.00 |
| CryoLife (CRY) | United States | $0.900B | 85.71 |
| Corindus Vascular Robotics (CVRS) | United States | $0.891B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.879B | 108.56 |
| Pacific Biosciences Of California (PACB) | United States | $0.812B | 0.00 |
| Intersect ENT (XENT) | United States | $0.560B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.554B | 19.89 |
| OrthoPediatrics (KIDS) | United States | $0.541B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.538B | 0.00 |
| AxoGen (AXGN) | United States | $0.500B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.408B | 15.67 |
| Si-Bone (SIBN) | United States | $0.394B | 0.00 |
| Fluidigm (FLDM) | United States | $0.334B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.333B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.329B | 0.00 |
| Sientra (SIEN) | United States | $0.328B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.292B | 49.17 |
| IRadimed (IRMD) | United States | $0.267B | 44.23 |
| ViewRay (VRAY) | United States | $0.246B | 0.00 |
| Accuray (ARAY) | United States | $0.241B | 0.00 |
| Stereotaxis (STXS) | United States | $0.235B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.220B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.218B | 75.75 |
| RTI Surgical (RTIX) | United States | $0.199B | 29.89 |
| Neuronetics (STIM) | United States | $0.167B | 0.00 |
| ConforMIS (CFMS) | United States | $0.165B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.139B | 68.57 |
| T2 Biosystems (TTOO) | United States | $0.114B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.106B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.094B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.077B | 0.00 |
| TransEnterix (TRXC) | United States | $0.067B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.061B | 0.00 |
| Electromed (ELMD) | United States | $0.058B | 29.78 |
| Ekso Bionics Holdings (EKSO) | United States | $0.053B | 0.00 |
| Vermillion (VRML) | United States | $0.052B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.044B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.043B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.040B | 0.00 |
| Nuvectra (NVTR) | United States | $0.033B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.032B | 0.00 |
| Neovasc (NVCN) | Canada | $0.028B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.022B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.018B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.017B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.014B | 20.42 |
| Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.013B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.012B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.011B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.011B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.008B | 0.00 |
| Dynatronics (DYNT) | United States | $0.008B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.007B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.005B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.004B | 0.00 |
| InspireMD (NSPR) | Israel | $0.002B | 0.00 |
